Wealth Effects LLC Increases Stock Position in Stereotaxis, Inc. (NYSEAMERICAN:STXS)

Wealth Effects LLC boosted its holdings in shares of Stereotaxis, Inc. (NYSEAMERICAN:STXS) by 11.7% during the 4th quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 86,060 shares of the company’s stock after buying an additional 9,000 shares during the quarter. Wealth Effects LLC owned approximately 0.10% of Stereotaxis worth $196,000 as of its most recent SEC filing.

A number of other large investors also recently bought and sold shares of the business. SG Americas Securities LLC purchased a new position in shares of Stereotaxis in the 3rd quarter worth approximately $39,000. Jane Street Group LLC increased its position in shares of Stereotaxis by 26.9% during the third quarter. Jane Street Group LLC now owns 29,773 shares of the company’s stock worth $61,000 after purchasing an additional 6,313 shares in the last quarter. Rhumbline Advisers lifted its holdings in shares of Stereotaxis by 645.6% during the 2nd quarter. Rhumbline Advisers now owns 48,251 shares of the company’s stock valued at $88,000 after purchasing an additional 41,780 shares during the last quarter. Barclays PLC boosted its position in shares of Stereotaxis by 449.9% in the 3rd quarter. Barclays PLC now owns 101,953 shares of the company’s stock worth $208,000 after purchasing an additional 83,412 shares in the last quarter. Finally, Charles Schwab Investment Management Inc. grew its stake in Stereotaxis by 10.2% during the 3rd quarter. Charles Schwab Investment Management Inc. now owns 167,297 shares of the company’s stock worth $341,000 after buying an additional 15,491 shares during the last quarter. Institutional investors own 45.35% of the company’s stock.

Stereotaxis Stock Down 0.4 %

Shares of Stereotaxis stock opened at $2.30 on Wednesday. Stereotaxis, Inc. has a 12-month low of $1.66 and a 12-month high of $3.29.

Stereotaxis (NYSEAMERICAN:STXS) last announced its quarterly earnings data on Monday, November 11th. The company reported ($0.08) earnings per share for the quarter, missing analysts’ consensus estimates of ($0.05) by ($0.03). The firm had revenue of $9.20 million during the quarter, compared to analyst estimates of $6.80 million. Stereotaxis had a negative net margin of 85.79% and a negative return on equity of 162.54%. Analysts forecast that Stereotaxis, Inc. will post -0.26 earnings per share for the current year.

Stereotaxis Profile

Stereotaxis, Inc designs, manufactures, and markets robotic systems, instruments, and information systems for the interventional laboratory in the United States and internationally. Its robotic magnetic navigation (RMN) systems include the Genesis RMN and Niobe systems, which enable physicians to complete complex interventional procedures by providing image-guided delivery of catheters and guidewires through the blood vessels and chambers of the heart to treatment sites.